Stage IV HER2-negative gastric adenocarcinoma complicated by acute arterial thrombosis during chemotherapy

This gastric cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Subtype
Adenocarcinoma
Biomarkers
HER2-negative
Sex
Male
Spread to
peritoneum, retroperitoneal lymph nodes
Treatment
chemotherapy
Outcome
Care Ongoing

Treatment course, step by step

  1. Started epirubicin, oxaliplatin and capecitabine combination chemotherapy.
  2. Treatment was stopped after the first cycle when extensive acute arterial thrombosis developed.
  3. Six weeks later, started single-agent docetaxel chemotherapy.

What happened, in summary

A 70-year-old man presented with 3 months of weight loss and early satiety. Endoscopy showed a large gastric tumor extending from the gastroesophageal junction toward the lower stomach. Biopsy confirmed poorly differentiated gastric adenocarcinoma, and HER2 testing was negative. CT showed peritoneal and retroperitoneal nodal metastases, establishing Stage IV disease.

He started combination chemotherapy with epirubicin, oxaliplatin and capecitabine. Five days after the first cycle, he developed sudden severe abdominal and back pain. Urgent CT angiography found extensive new arterial thrombosis in the abdominal aorta and branches. Chemotherapy was stopped, and he was treated with anticoagulation and supportive care. He recovered without surgery and was discharged on long-term enoxaparin.

The patient remained eager to continue cancer treatment. Because of the thrombosis risk, the platinum-based regimen was not restarted. Six weeks after the acute event, he began single-agent docetaxel. At the latest follow-up, he remained well and had experienced no further complications.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar gastric cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more gastric cancer stories